Does TOFACITINIB Cause Injection site reaction? 698 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 698 reports of Injection site reaction have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.5% of all adverse event reports for TOFACITINIB.
698
Reports of Injection site reaction with TOFACITINIB
0.5%
of all TOFACITINIB reports
279
Deaths
523
Hospitalizations
How Dangerous Is Injection site reaction From TOFACITINIB?
Of the 698 reports, 279 (40.0%) resulted in death, 523 (74.9%) required hospitalization, and 273 (39.1%) were considered life-threatening.
Is Injection site reaction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 698 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Injection site reaction?
ETANERCEPT (9,962)
ADALIMUMAB (4,375)
NALTREXONE (4,360)
DUPILUMAB (4,129)
GLATIRAMER (3,317)
IXEKIZUMAB (1,701)
METHOTREXATE (1,663)
TIRZEPATIDE (1,389)
TOCILIZUMAB (1,343)
CERTOLIZUMAB PEGOL (1,253)
Which TOFACITINIB Alternatives Have Lower Injection site reaction Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN